MHRA announces Good Clinical Practice (GCP) Discussion Forum
The U.K. Medicines and Healthcare products Regulatory Agency MHRA has created a GCP Discussion Forum to help all those involved in the conduct of clinical trials implement quality procedures that can ensure compliance with clinical trials legislation and GCP requirements.
The platform also provides the ideal opportunity for an extended communication between researchers and allows users to put forward their comments and get 'real-life' examples.
Related GMP News
17.07.2025ICH E20 Draft Guideline on Adaptive Design for Clinical Trials
17.07.2025Update on ICH Guidelines E21 & E22
10.07.2025EMA Policy on the Publication of Clinical Data
17.06.2025EMA Implementation of ICH E6, M11 & M12
03.04.2025Update on the ICH M11 CeSHArP Technical Specification
03.04.2025EU Map to Clinical Trials